Biotech Questions and Answers Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Questions and Answers

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bert Klimer who wrote (9)	1/4/1999 5:27:00 PM
From: Bosco	Read Replies (2) of 30

G'day all - Bert, thx for starting this thread. Don't know much about the co you mentioned, but biotech is a tough biz these days. That is the reason why people tend to be more willing to pay premium for large phamaceuticals and the top dogs like Amgen. I am holding two or three microcaps in the red. At least, they have good balance sheets, so I am holding them for now [note: I did get burn before - thought I ve learned <sg>.] Clinical trials [I thru III] can have high burnt rate. Any sign of FDA rejection can take 60% off the share price in a single day [of course, the reward of approval can be equally rewarding!] which in turn can do serious harm to the co's ability to raise capital. Without going to deep in your perspective stock[s]. It may worth your while to figure out what kind of apps they are doing. Any treatment for life threatening disease gets priority status called "fast track." [note: I understand that some people invest in life science for more than just profit. Maybe for an application to a disease that touches their personal lives. Sometimes, going with their heart can be doubly rewarding, if the investment pans out.] good luck best, Bosco

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next